Please note that registrations to the site are currently unavailable due to an upgrade of the site. If you need something urgently, please contact help@prescqipp.info
This bulletin reviews the place in therapy for subcutaneous Infliximab which may help reduce capacity problems with providers during the current pandemic. A cost calculator tool template is available as a supporting resource.
